BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 9017275)

  • 21. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
    Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
    Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obesity and metabolic complications: contribution of dehydroepiandrosterone and other steroid hormones.
    Tchernof A; Labrie F; Bélanger A; Després JP
    J Endocrinol; 1996 Sep; 150 Suppl():S155-64. PubMed ID: 8943799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The interactions between hypothalamic-pituitary-adrenal axis activity, testosterone, insulin-like growth factor I and abdominal obesity with metabolism and blood pressure in men.
    Rosmond R; Björntorp P
    Int J Obes Relat Metab Disord; 1998 Dec; 22(12):1184-96. PubMed ID: 9877254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The hypothalamic-pituitary-adrenal axis activity in obesity and the metabolic syndrome.
    Pasquali R; Vicennati V; Cacciari M; Pagotto U
    Ann N Y Acad Sci; 2006 Nov; 1083():111-28. PubMed ID: 17148736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Melancholic depression and abdominal fat distribution: a mini-review.
    Mann JN; Thakore JH
    Stress; 1999 Aug; 3(1):1-15. PubMed ID: 19016189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypothalamic arousal, insulin resistance and Type 2 diabetes mellitus.
    Björntorp P; Holm G; Rosmond R
    Diabet Med; 1999 May; 16(5):373-83. PubMed ID: 10342336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities.
    Rosmond R; Dallman MF; Björntorp P
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1853-9. PubMed ID: 9626108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stress mechanisms and metabolic complications.
    Kyrou I; Tsigos C
    Horm Metab Res; 2007 Jun; 39(6):430-8. PubMed ID: 17578760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroendocrine perturbations as a cause of insulin resistance.
    Björntorp P
    Diabetes Metab Res Rev; 1999; 15(6):427-41. PubMed ID: 10634968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased cortisol bioavailability, abdominal obesity, and the metabolic syndrome in obese women.
    Duclos M; Marquez Pereira P; Barat P; Gatta B; Roger P
    Obes Res; 2005 Jul; 13(7):1157-66. PubMed ID: 16076984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypothalamic pathogenesis of type 2 diabetes.
    Koshiyama H; Hamamoto Y; Honjo S; Wada Y; Lkeda H
    Med Hypotheses; 2006; 67(2):307-10. PubMed ID: 16616435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of body fat composition and serum adiponectin levels in diabetic obesity and non-diabetic obesity.
    Kim C; Park J; Park J; Kang E; Ahn C; Cha B; Lim S; Kim K; Lee H
    Obesity (Silver Spring); 2006 Jul; 14(7):1164-71. PubMed ID: 16899797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The hypothalamic-pituitary-adrenal and the hypothalamic- pituitary-gonadal axes interplay.
    Mastorakos G; Pavlatou MG; Mizamtsidi M
    Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():172-81. PubMed ID: 16641855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dysregulation of the autonomic nervous system can be a link between visceral adiposity and insulin resistance.
    Lindmark S; Lönn L; Wiklund U; Tufvesson M; Olsson T; Eriksson JW
    Obes Res; 2005 Apr; 13(4):717-28. PubMed ID: 15897481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Metabolic difference between visceral fat and subcutaneous abdominal fat].
    Björntorp P
    Diabetes Metab; 2000 Jun; 26 Suppl 3():10-2. PubMed ID: 10945144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroendocrine abnormalities in visceral obesity.
    Björntorp P; Rosmond R
    Int J Obes Relat Metab Disord; 2000 Jun; 24 Suppl 2():S80-5. PubMed ID: 10997616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic implications of body fat distribution.
    Björntorp P
    Diabetes Care; 1991 Dec; 14(12):1132-43. PubMed ID: 1773700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The metabolic syndrome--a neuroendocrine disorder?
    Björntorp P; Rosmond R
    Br J Nutr; 2000 Mar; 83 Suppl 1():S49-57. PubMed ID: 10889792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Endocrine and metabolic consequences of massive obesity].
    Fossati P; Fontaine P
    Rev Prat; 1993 Oct; 43(15):1935-9. PubMed ID: 8310248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endocrine abnormalities of obesity.
    Björntorp P
    Metabolism; 1995 Sep; 44(9 Suppl 3):21-3. PubMed ID: 7674912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.